These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19563854)

  • 1. Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
    Chen CK; Wu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1279-80. PubMed ID: 19563854
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy.
    Caykoylu A; Ekinci O; Yilmaz E
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):571-2. PubMed ID: 19302830
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1342-3. PubMed ID: 18433967
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder.
    Chen MH; Liou YJ
    J Clin Psychopharmacol; 2013 Apr; 33(2):269-70. PubMed ID: 23422384
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement in tardive dyskinesia with aripiprazole use.
    Witschy JK; Winter AS
    Can J Psychiatry; 2005 Mar; 50(3):188. PubMed ID: 15830835
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.
    Suzuki Y; Ono S; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Someya T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):643-4. PubMed ID: 21044656
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
    Hettema JM; Ross DE
    J Clin Psychiatry; 2007 Nov; 68(11):1814-5. PubMed ID: 18052582
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 11. Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient.
    Hung GC; Chen YY
    Pharmacopsychiatry; 2007 Mar; 40(2):83-4. PubMed ID: 17447180
    [No Abstract]   [Full Text] [Related]  

  • 12. Aripiprazole treatment for risperidone-associated tic movement: a case report.
    Su JA; Tsang HY; Chou SY; Chung PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):899-900. PubMed ID: 18166258
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin.
    De Berardis D; Serroni N; Moschetta FS; Martinotti G; Di Giannantonio M
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E9-10. PubMed ID: 23686043
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series.
    Chen CY; Lin TY; Wang CC; Shuai HA
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):95-7. PubMed ID: 21265942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
    De Schutter P; Bouckaert F; Peuskens J
    Tijdschr Psychiatr; 2011; 53(5):299-303. PubMed ID: 21538299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Courses of aripiprazole-associated tardive dyskinesia: report of two cases.
    Wang LJ; Ree SC; Chen CK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):743-4. PubMed ID: 19344742
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of delusional disorder with low-dose aripiprazole.
    Miyamoto S; Miyake N; Ogino S; Endo T; Yamaguchi N
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):369. PubMed ID: 18588606
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
    Lin SK; Chen CK
    J Clin Psychiatry; 2006 Aug; 67(8):1307. PubMed ID: 16965214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.